Who owns Novogen?

Key details on Novogen

Who owns Novogen?

Is Novogen a good stock to own? Find out who bought Novogen, who sold Novogen stock, and who holds a large position in Novogen.

Fund Name Number of Shares Share Valuation As Of
Jefferies 111854 $777385 Dec. 31, 2012
Gilman Hill Asset Management 23471 $162888 Dec. 31, 2012
Muhlenkamp & Company 18184 $126015 Dec. 31, 2012
Renaissance Technologies 15240 $67970 June 30, 2013
KCG Holdings 14649 $61965 Dec. 31, 2013
Knight Capital 13948 $33056 March 31, 2012
CITADEL ADVISORS 12637 $51938 March 31, 2014
FIRST NEW YORK SECURITIES 5200 $35984 Dec. 31, 2012
Bank of America Corporation 5035 $15105 Sept. 30, 2014
National Asset Management 3200 $11776 June 30, 2014
MORGAN STANLEY 2304 $0 Sept. 30, 2014
Tower Research Capital 2255 $5998 Sept. 30, 2014
UBS AG 1199 $2398 Sept. 30, 2014
Baltimore-Washington Financial Advisors 1110 $3996 June 30, 2014
Citi 310 $1001 Dec. 31, 2013
Creative Planning 200 $1000 Sept. 30, 2014
Palladium Partners,LLC dba Palladium Registered Investment Advisors 200 $1000 March 31, 2014
Baltimore-Washington Financial Advisors 110 $0 Sept. 30, 2013
Ground Swell Capital 100 $284 Sept. 30, 2014
Ameriprise Financial 78 $0 June 30, 2014
BlackRock 9 $0 June 30, 2013